Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.
Where this comes from
- Record sourced from PubMed, PMID 20024046.
- Also identified by DOI 10.1039/b917959c and PMC identifier 3031459.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Geometrically enhanced differential immunocapture (GEDI) and an antibody for prostate-specific membrane antigen (PSMA) are used for high-efficiency and high-purity capture of prostate circulating tumor cells from peripheral whole blood samples of castrate-resistant prostate cancer patients.
Medical subject headings
- Antibodies, Immobilized
- Immunoassay
- Microfluidic Analytical Techniques
- Neoplastic Cells, Circulating
- Prostate-Specific Antigen
- Prostatic Neoplasms